These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30059128)

  • 41. Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
    Welsh P; Kou L; Yu C; Anand I; van Veldhuisen DJ; Maggioni AP; Desai AS; Solomon SD; Pfeffer MA; Cheng S; Gullestad L; Aukrust P; Ueland T; Swedberg K; Young JB; Kattan MW; Sattar N; McMurray JJV
    Eur J Heart Fail; 2018 Feb; 20(2):268-277. PubMed ID: 28960777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure.
    Pérez-Calvo JI; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Manzano-Fernández S; Galisteo-Almeda L; Pascual-Figal D
    Eur J Intern Med; 2012 Oct; 23(7):599-603. PubMed ID: 22939803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
    J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trimethylamine N-oxide and prognosis in acute heart failure.
    Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
    Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction.
    Pérez-Calvo JI; Morales-Rull JL; Gimeno-Orna JA; Lasierra-Díaz P; Josa-Laorden C; Puente-Lanzarote JJ; Bettencourt P; Pascual-Figal DA
    Am J Cardiol; 2016 Aug; 118(4):543-9. PubMed ID: 27338207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure.
    Lüers C; Schmidt A; Wachter R; Fritzsche F; Sutcliffe A; Kleta S; Zapf A; Hagenah G; Binder L; Maisch B; Pieske B
    Herz; 2010 Oct; 35(7):488-95. PubMed ID: 20927502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
    Luers C; Sutcliffe A; Binder L; Irle S; Pieske B
    Clin Biochem; 2013 Aug; 46(12):1013-1019. PubMed ID: 23542086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The prognostic role of extremely high levels of the B-type natriuretic prohormone with regard to the in-hospital mortality of patients hospitalized for heart failure].
    Bózsik B; Nagy E; Somlói M; Tomcsányi J
    Orv Hetil; 2017 May; 158(20):779-782. PubMed ID: 28502208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Value of admission NT-proBNP in predicting in-hospital mortality in decompensated systolic heart failure].
    Wei BQ; Yang YJ; Zhang J; Zhang YH; Kang LM; Dou KF; Wang D; Lü R; Gao X; Yu LT; Wang GG; Yang YM; Tan HQ; Zhu J
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1955-9. PubMed ID: 19950568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 57. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure.
    Velibey Y; Golcuk Y; Golcuk B; Oray D; Atilla OD; Colak A; Kurtulmus Y; Erbay AR; Yilmaz A; Eren M
    Am J Emerg Med; 2013 Dec; 31(12):1634-7. PubMed ID: 24055249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
    Chuang CP; Jong YS; Wu CY; Lo HM
    Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.